Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Old drugs still work! Oral etoposide in a relapsed medulloblastoma.

Perez-Somarriba M, Andión M, López-Pino MA, Lavarino C, Madero L, Lassaletta A.

Childs Nerv Syst. 2019 May;35(5):865-869. doi: 10.1007/s00381-019-04072-9. Epub 2019 Feb 1.

PMID:
30707305
2.

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.

Hagemeister FB.

Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. Epub 2002 Apr 12. Review.

PMID:
12042984
3.

Relapse in medulloblastoma: what can be done after abandoning high-dose chemotherapy? A mono-institutional experience.

Massimino M, Casanova M, Polastri D, Biassoni V, Modena P, Pecori E, Schiavello E, De Pava MV, Indini A, Rampini P, Bauer D, Catania S, Podda M, Gandola L.

Childs Nerv Syst. 2013 Jul;29(7):1107-12. doi: 10.1007/s00381-013-2104-x. Epub 2013 Apr 18.

PMID:
23595805
4.

A Phase II feasibility study of oral etoposide given concurrently with radiotherapy followed by dose intensive adjuvant chemotherapy for children with newly diagnosed high-risk medulloblastoma (protocol POG 9631): A report from the Children's Oncology Group.

Esbenshade AJ, Kocak M, Hershon L, Rousseau P, Decarie JC, Shaw S, Burger P, Friedman HS, Gajjar A, Moghrabi A.

Pediatr Blood Cancer. 2017 Jun;64(6). doi: 10.1002/pbc.26373. Epub 2016 Dec 21.

5.

Irinotecan, vincristine, cisplatin, cyclophosphamide, and etoposide for refractory or relapsed medulloblastoma/PNET in pediatric patients.

Kim H, Kang HJ, Lee JW, Park JD, Park KD, Shin HY, Ahn HS.

Childs Nerv Syst. 2013 Oct;29(10):1851-8. doi: 10.1007/s00381-013-2163-z. Epub 2013 Jun 9.

PMID:
23748464
6.

Phase I study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma.

Ruggiero A, Rizzo D, Attinà G, Lazzareschi I, Mastrangelo S, Maurizi P, Migliorati R, Bertolini P, Pastore M, Colosimo C, Riccardi R.

Eur J Cancer. 2010 Nov;46(16):2943-9. doi: 10.1016/j.ejca.2010.05.016. Epub 2010 Jun 9.

PMID:
20538454
7.
9.

Metastatic medulloblastoma in 10-year-old girl treated successfully with chemotherapy without radiotherapy.

Schiavetti A, Varrasso G, Maurizi P, Trasimeni G, Carapella C, Castello MA.

J Neurooncol. 1999;45(1):55-60.

PMID:
10728910
10.

Adult medulloblastoma: multiagent chemotherapy.

Greenberg HS, Chamberlain MC, Glantz MJ, Wang S.

Neuro Oncol. 2001 Jan;3(1):29-34. doi: 10.1093/neuonc/3.1.29. Review.

11.
12.

Activity of postoperative carboplatin, etoposide, and high-dose methotrexate in pediatric CNS embryonal tumors: results of a phase II study in newly diagnosed children.

Kellie SJ, Wong CK, Pozza LD, Waters KD, Lockwood L, Mauger DC, White L.

Med Pediatr Oncol. 2002 Sep;39(3):168-74.

PMID:
12210445
13.

High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor.

Sung KW, Yoo KH, Cho EJ, Koo HH, Lim DH, Shin HJ, Ahn SD, Ra YS, Choi ES, Ghim TT.

Pediatr Blood Cancer. 2007 Apr;48(4):408-15.

PMID:
17066462
14.
15.

Response of recurrent medulloblastoma to low-dose oral etoposide.

Ashley DM, Meier L, Kerby T, Zalduondo FM, Friedman HS, Gajjar A, Kun L, Duffner PK, Smith S, Longee D.

J Clin Oncol. 1996 Jun;14(6):1922-7.

PMID:
8656261
16.

Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.

Lee YC, McCrystal MR, Christmas TI.

N Z Med J. 1998 Nov 27;111(1078):451-2, 453-4.

PMID:
9891564
17.

Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: a phase II study.

Kovnar EH, Kellie SJ, Horowitz ME, Sanford RA, Langston JW, Mulhern RK, Jenkins JJ, Douglass EC, Etcubanas EE, Fairclough DL, et al.

J Clin Oncol. 1990 Feb;8(2):330-6. Review.

PMID:
2153766
18.

Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols.

Dhall G, Grodman H, Ji L, Sands S, Gardner S, Dunkel IJ, McCowage GB, Diez B, Allen JC, Gopalan A, Cornelius AS, Termuhlen A, Abromowitch M, Sposto R, Finlay JL.

Pediatr Blood Cancer. 2008 Jun;50(6):1169-75. doi: 10.1002/pbc.21525.

PMID:
18293379
19.

Successful Use of Dose Dense Neoadjuvant Chemotherapy and Sodium Valproate with Minimal Toxicity in an Infant with Medulloblastoma in Extremely Poor General Condition.

Gupta A, Kumar A, Abrari A, Patir R, Vaishya S.

World Neurosurg. 2016 Sep;93:485.e1-5. doi: 10.1016/j.wneu.2016.07.044. Epub 2016 Jul 20.

PMID:
27450977
20.

The therapy of infantile malignant brain tumors: current status?

Kalifa C, Grill J.

J Neurooncol. 2005 Dec;75(3):279-85. Review.

PMID:
16195802

Supplemental Content

Support Center